OFEV.com


Idiopathic Pulmonary Fibrosis (IPF) is a chronic, life-threatening condition where lung tissue becomes scarred over a period of time, leading to a patient’s inability to transfer oxygen into their bloodstream. Boehringer Ingelheim is a leader in respiratory care with a focus on IPF and improving the quality of life of those who suffer from this very rare disease. OFEV is the leading pharmaceutical treatment for IPF, and I helped build it’s online direct to consumer brand.


Creative Director: Nathan Gomez
Art Director: Nathan Gamson
Copywriter: Lori Hodgen
UX Lead: Anup Sheth
Client: Boehringer Ingelheim
Agency: Wunderman Thompson